Researchers have engineered an anti-cancer antibody that attaches specifically to cancer cells and summons immune killer cells to destroy the target.
Read more
Category: biotech/medical – Page 2379
Russian researchers from the Moscow Institute of Physics and Technology (MIPT), the Technological Institute for Superhard and Novel Carbon Materials (TISNCM), and the National University of Science and Technology MISIS have optimized the design of a nuclear battery generating power from the beta decay of nickel-63, a radioactive isotope. Their new battery prototype packs about 3,300 milliwatt-hours of energy per gram, which is more than in any other nuclear battery based on nickel-63, and 10 times more than the specific energy of commercial chemical cells. The paperwas published in the journal Diamond and Related Materials.
Conventional batteries
Ordinary batteries powering clocks, flashlights, toys, and other compact autonomous electrical devices use the energy of so-called redox chemical reactions. In them, electrons are transferred from one electrode to another via an electrolyte. This gives rise to a potential difference between the electrodes. If the two battery terminals are then connected by a conductor, electrons start flowing to remove the potential difference, generating an electric current. Chemical batteries, also known as galvanic cells, are characterized by a high power density — that is, the ratio between the power of the generated current and the volume of the battery. However, chemical cells discharge in a relatively short time, limiting their applications in autonomous devices. Some of these batteries, called accumulators, are rechargeable, but even they need to be replaced for charging. This may be dangerous, as in the case of a cardiac pacemaker, or even impossible, if the battery is powering a spacecraft.
Read more
The human eye is a remarkably sophisticated organ and like the lens to a camera, it’s the cornea that focuses the flood of photons into a perceptible image. But for an estimated 15 million people around the world, eye disease and trauma make surgery the only path to clear vision.
In the next few years, artificial corneas may become more accessible thanks to new research out of Newcastle University in the United Kingdom. There, researchers mixed stem cells from the cornea of a healthy donor with collagen and algae molecules to create a bio-ink, which they 3D-printed into an artificial cornea. The research is currently just a proof-of-concept but lays the groundwork for future techniques to create low-cost, easy-to-produce bionic eyes.
There were three features required for the bio-ink, according to Che Connon, a professor of tissue engineering at Newcastle.
Read more
LEAF’s monthly roundup for May is out!
Summer is coming, and, albeit on a slightly longer timeframe, so is a world free of aging! So, grab an iced drink, sit comfortably on your beach chair, and let’s have a look together at some of the latest rejuvenation news.
The first LEAF conference in NYC is coming!
May saw us announce Ending Age-Related Diseases: Investment Prospects & Advances in Research, a special one-day conference taking place on July 12th in the heart of New York City. Join us for an action-packed day of research and biotech investment talks and panels from industry leaders as we build the longevity research and investment ecosystem!
With the ability to be coaxed into different kinds of mature cell types, induced pluripotent stem cells (iPSCs) hold all kinds of potential in the world of regenerative medicine. One of the many possibilities could be repairing damaged hearts, something that will soon be put to the test for the first time ever in newly approved clinical trials in Japan.
Since emerging from the laboratory of researcher Shinya Yamanaka in Japan in 2006, the potential of iPSCs has been explored in all kinds of promising research efforts. We have seen them implanted into rabbits to restore their vision, become brain tumor predators, and turned into precursor cells for human organs.
IPSCs are created by first harvesting cells from body tissues and then infecting them with a virus, in turn introducing them to carefully selected genes that return them to their immature state. From there they can develop into any cell in the body, a capability so powerful it earned Yamanaka a Nobel Prize in 2012.
Read more
Researchers at Queen Mary University of London have developed a new way to grow mineralised materials which could regenerate hard tissues such as dental enamel and bone.
Enamel, located on the outer part of our teeth, is the hardest tissue in the body and enables our teeth to function for a large part of our lifetime despite biting forces, exposure to acidic foods and drinks and extreme temperatures. This remarkable performance results from its highly organised structure.
However, unlike other tissues of the body, enamel cannot regenerate once it is lost, which can lead to pain and tooth loss. These problems affect more than 50 per cent of the world’s population and so finding ways to recreate enamel has long been a major need in dentistry.
Read more
Forget zombies or killer robots – the most likely doomsday scenario in the near future is the threat of superbugs. Bacteria are evolving resistance to our best antibiotics at an alarming rate, so developing new ones is a crucial area of study. Now, inspired by a natural molecule produced by marine microorganisms, researchers at North Carolina State University have synthesized a new compound that shows promising antibacterial properties against resistant bugs.
Decades of overuse and overprescription of antibiotics has led to more and more bacteria becoming resistant to them, and the situation is so dire that a recent report warned that they could be killing up to 10 million people a year by 2050. Worse still, the bugs seem to be on schedule, with the ECDC reporting that our last line of defense has already begun to fail in large numbers.
Read more
https://www.engadget.com/…/3D-printed-brain-medical-imagin…/
There are almost limitless possibilities when it comes to 3D printing. Design your own color-changing jewelry? Fine. Fabricate your own drugs? No problem. Print an entire house in under 24 hours? Sure! Now, researchers have come up with a fast and easy way to print palm-sized models of individual human brains, presumably in a bid to advance scientific endeavours, but also because, well, that’s pretty neat.
In theory, creating a 3D printout of a human brain has been done before, using data from MRI and CT scans. But as MIT graduate Steven Keating found when he wanted to examine his own brain following his surgery to remove a baseball-sized tumour, it’s a slow, cumbersome process that doesn’t reveal any important areas of interest.
MRI and CT scans produce images with so much detail that objects of interest need to be isolated from surrounding tissue and converted into surface meshes in order to be printed. This involves a radiologist manually tracing the desired object onto every single image “slice” of the brain, or it can be done via automatic thresholding, where a computer converts areas that contain grayscale pixels into either solid black or solid white pixels, based on a shade of gray that is chosen to be the threshold between black and white. But since medical imaging data often contains irregularly-shaped objects and lacks clear borders, features of interest are usually over- or under-exaggerated, and details are washed out.
When I am Eighty-Five
Posted in biotech/medical, business, life extension
I will be 85 somewhere in the mid 2050s. It seems like a mirage, an impossible thing, but the future eventually arrives regardless of whatever you or I might think about it. We all have a vision of what it is to be 85 today, informed by our interactions with elder family members, if nothing else. People at that age are greatly impacted by aging. They falter, their minds are often slowed. They are physically weak, in need of aid. Perhaps that is why we find it hard to put ourselves into that position; it isn’t a pleasant topic to think about. Four decades out into the future may as well be a science fiction novel, a far away land, a tale told to children, for all the influence it has on our present considerations. There is no weight to it.
When I am 85, there will have been next to no senescent cells in my body for going on thirty years. I bear only a small fraction of the inflammatory burden of older people of past generations. I paid for the products of companies descended from Oisin Biotechnologies and Unity Biotechnology, every few years wiping away the accumulation of senescent cells, each new approach more effective than the last. Eventually, I took one of the permanent gene therapy options, made possible by biochemical discrimination between short-term beneficial senescence and long-term harmful senescence, and then there was little need for ongoing treatments. Artificial DNA machinery floats in every cell, a backup for the normal mechanisms of apoptosis, triggered by lingering senescence.
When I am 85, the senolytic DNA machinery will be far from the only addition to my cells. I underwent a half dozen gene therapies over the years. I picked the most useful of the many more that were available, starting once the price fell into the affordable-but-painful range, after the initial frenzy of high-cost treatments subsided into business as usual. My cholesterol transport system is enhanced to attack atherosclerotic lesions, my muscle maintenance and neurogenesis operate at levels far above what was once a normal range for my age, and my mitochondria are both enhanced in operation and well-protected against damage by additional copies of mitochondrial genes backed up elsewhere in the cell. Some of these additions were rendered moot by later advances in medicine, but they get the job done.
Read more